[go: up one dir, main page]

WO2016015055A8 - Colon cleansing compositions - Google Patents

Colon cleansing compositions Download PDF

Info

Publication number
WO2016015055A8
WO2016015055A8 PCT/US2015/042298 US2015042298W WO2016015055A8 WO 2016015055 A8 WO2016015055 A8 WO 2016015055A8 US 2015042298 W US2015042298 W US 2015042298W WO 2016015055 A8 WO2016015055 A8 WO 2016015055A8
Authority
WO
WIPO (PCT)
Prior art keywords
colon cleansing
cleansing compositions
compositions
kits
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2015/042298
Other languages
French (fr)
Other versions
WO2016015055A1 (en
Inventor
Mark G. Currie
Caroline Kurtz
Jeffrey Johnston
Xiaobing Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ironwood Pharmaceuticals Inc
Original Assignee
Ironwood Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ironwood Pharmaceuticals Inc filed Critical Ironwood Pharmaceuticals Inc
Publication of WO2016015055A1 publication Critical patent/WO2016015055A1/en
Publication of WO2016015055A8 publication Critical patent/WO2016015055A8/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10Peptides having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to compositions comprising guanylate cyclase C agonist peptides, and dosage forms, methods, and kits thereof. The compositions, dosage forms, methods and kits may be used for colon cleansing prior to colonoscopy, or in preparation for other medical, radiologic and/or surgical procedures.
PCT/US2015/042298 2014-07-25 2015-07-27 Colon cleansing compositions Ceased WO2016015055A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462028963P 2014-07-25 2014-07-25
US62/028,963 2014-07-25

Publications (2)

Publication Number Publication Date
WO2016015055A1 WO2016015055A1 (en) 2016-01-28
WO2016015055A8 true WO2016015055A8 (en) 2016-09-09

Family

ID=53777040

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2015/042298 Ceased WO2016015055A1 (en) 2014-07-25 2015-07-27 Colon cleansing compositions

Country Status (1)

Country Link
WO (1) WO2016015055A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE061954T2 (en) * 2015-05-01 2023-09-28 Ironwood Pharmaceuticals Inc Compositions for colon cleansing and the treatment of gastrointestinal disorders
RU2713175C1 (en) * 2019-02-04 2020-02-04 Виктор Анатольевич Маткевич Acid-mineral composition and enteral solution by matkevich for lavage of gastrointestinal tract and/or correction of homeostasis disorders
KR20220122613A (en) * 2019-12-23 2022-09-02 주식회사 비보존 colon laxative composition
CN115040512B (en) * 2022-07-28 2023-06-20 苏州中化药品工业有限公司 Pharmaceutical composition and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2620153T3 (en) * 2009-11-09 2017-06-27 Ironwood Pharmaceuticals, Inc. Treatments for gastrointestinal disorders
US20160213739A1 (en) * 2011-05-11 2016-07-28 Ironwood Pharmaceuticals, Inc Treatments for disorders using guanylate cyclase c agonists
US9303066B2 (en) * 2011-05-11 2016-04-05 Ironwood Pharmaceuticals, Inc. Treatments for gastrointestinal disorders
CA2902348C (en) * 2013-02-25 2021-11-30 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses

Also Published As

Publication number Publication date
WO2016015055A1 (en) 2016-01-28

Similar Documents

Publication Publication Date Title
EP3665181A4 (en) Compositions and methods for decolonizing antibotic-resistant bacteria in the gut
WO2016044463A3 (en) Mk2 inhibitors and uses thereof
IL273300A (en) High dosage valbenazine formulation and compositions, methods, and kits related thereto
CA2956871C (en) Compounds active towards bromodomains
WO2016073789A3 (en) Anti-fgfr2/3 antibodies and methods using same
EP3164702A4 (en) Use of fluorescent polymers in marking compositions for the diagnostic determination of cleaning performance
WO2016011306A3 (en) Terminal modifications of polynucleotides
WO2016060996A3 (en) Interleukin-15 compositions and uses thereof
EP3119432A4 (en) Antibodies against immunogenic glycopeptides, composition comprising the same and use thereof
WO2014152157A8 (en) Methods and compositions for the generation and use of conformation-specific antibodies
WO2014180889A8 (en) Methods and compositions for the treatment of cancer
WO2015011694A3 (en) Isotopologues of smad7 antisense oligonucleotides
WO2015171558A3 (en) BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORγ AND THE TREATEMENT OF DISEASE
SG11201705450SA (en) Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases
WO2016140933A3 (en) Immediate release soluble ibuprofen compositions
WO2016079110A3 (en) Use of enzyme for cleaning
WO2015200534A3 (en) Small molecule agonists of neurotensin receptor 1
IL268997A (en) Compositions comprising pgi2-receptor agonists and processes for the preparation thereof
WO2016167944A3 (en) Compositions and methods for treating autism
WO2017075171A3 (en) Pamam dendrimer based cest imaging agents and uses thereof
WO2016094374A8 (en) Compositions and methods for treatment of friedreich's ataxia
WO2016015055A8 (en) Colon cleansing compositions
WO2017087917A3 (en) Bicarbonate biosensors, calcium biosensors, and uses thereof
EP3161490A4 (en) COMPOSITIONS AND METHODS FOR DETECTING HUMAN PEGIVIRUS 2 (HPgV-2)
EA201691792A1 (en) PHARMACEUTICAL COMPOSITIONS BASED ON VILDAGLIPTINA

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15745741

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15745741

Country of ref document: EP

Kind code of ref document: A1